EMERGENCY:Sudden severe worsening of balance, new swallowing difficulty, or a fall causing head injury in a patient with hereditary ataxia —call040-46324365immediately — 24 hours, 7 days— 24/7
Spinocerebellar Ataxia 12 (SCA12): When Tremor Is the First Sign of a Hereditary Ataxia
The most common spinocerebellar ataxia in India — and the predominant form in the Agarwal community. SCA12 typically presents with tremor of the arms and head before ataxia develops, causing it to be misdiagnosed as essential tremor for years. A single genetic blood test confirms the diagnosis.
Most Common
PPP2R2B
Tremor-First
Agarwal
Spinocerebellar Ataxia Type 12 (SCA12) is an autosomal dominant neurodegenerative condition caused by a CAG trinucleotide repeat expansion in the 5′ untranslated region of the PPP2R2B gene — which encodes the regulatory Bβ subunit of protein phosphatase 2A (PP2A), an important enzyme in neuronal signalling. SCA12 is distinct from most other spinocerebellar ataxias in both genetics and clinical presentation. Genetically, the repeat expansion is in the non-coding region of the gene rather than the coding region. Clinically, tremor — particularly of the arms and head (titubation) — typically appears first, often many years before cerebellar ataxia becomes apparent. This makes SCA12 the most commonly misdiagnosed of the SCAs, frequently labelled as essential tremor until the ataxia, cognitive features, or family history prompt genetic testing. SCA12 is the most prevalent SCA subtype in India overall, and within the Agarwal community — a North Indian mercantile community with significant populations in Hyderabad, Rajasthan, and across India — it accounts for a disproportionately high proportion of hereditary ataxia cases.
- What it is
- Autosomal dominant spinocerebellar ataxia caused by a CAG repeat expansion in the PPP2R2B gene. The most common SCA in India. Presents with tremor (arms, head) before progressive ataxia.
- Community association
- The Agarwal community has a high founder mutation frequency for SCA12. Any patient of Agarwal heritage presenting with progressive tremor, ataxia, or both should have PPP2R2B CAG repeat sizing as a first-line investigation.
- Why it is misdiagnosed
- The early tremor of SCA12 is clinically indistinguishable from essential tremor, and it partially responds to propranolol — reinforcing the wrong diagnosis. The key clue is the family history pattern (autosomal dominant, 50% risk in children) and the eventual emergence of cerebellar ataxia.
- Diagnosis
- PPP2R2B CAG repeat sizing — a targeted molecular genetic blood test. No MRI, no EMG, no lumbar puncture required for diagnosis. KIMS orders this test directly for any patient with appropriate clinical and family history.
- Treatment
- No disease-modifying treatment · Tremor management: propranolol, primidone, clonazepam · Gait and balance: physiotherapy and walking aids · Genetic counselling: 50% recurrence risk per child; predictive testing offered to at-risk family members.
- Contact KIMS
- 040-44885000 · Clinical genetics and family counselling at KIMS · No referral required.
| Fact | Details |
|---|---|
| Condition | Spinocerebellar Ataxia Type 12 (SCA12) |
| ICD-10 | G11.19 · Autosomal dominant cerebellar ataxia (other specified) |
| Gene | PPP2R2B · Chromosome 5q31–5q33 · Encodes protein phosphatase 2A regulatory subunit Bβ |
| Repeat location | 5′ untranslated region (UTR) of PPP2R2B — non-coding region (unlike most SCAs where the expansion is in the coding region) |
| Normal repeat range | ≤28 CAG repeats |
| Pathogenic range | ≥66 CAG repeats (intermediate alleles: 29–65 — significance uncertain) |
| Inheritance | Autosomal dominant · 50% risk for each child of an affected parent · Both sexes affected equally |
| Age of onset | Variable: typically fourth to sixth decade · Later onset than SCA1, SCA2, SCA3 |
| First symptom | Tremor (arms, head) in the majority — NOT ataxia · This distinguishes SCA12 from all other common SCAs |
| Community association | Agarwal community (North Indian mercantile community): highest reported prevalence of SCA12 globally · Published founder mutation studies confirm a high mutation carrier frequency in this population |
| Most common SCA in India | SCA12 accounts for the largest proportion of SCA cases in Indian genetic ataxia registries — significantly higher than in Western populations where SCA1, SCA2, SCA3, and SCA6 predominate |
| Diagnostic test | PPP2R2B CAG repeat sizing · Single blood test · Available through molecular genetics laboratories · KIMS coordinates testing |
About This Condition
What Makes SCA12 Different from Other SCAs?
The name spinocerebellar ataxia describes what most of these conditions do first. SCA12 does something else first — and that difference is why it is the most commonly misdiagnosed SCA.
Tremor first, ataxia later
Most spinocerebellar ataxias present with progressive cerebellar ataxia as the dominant early feature. SCA12 breaks this pattern: in the majority of patients, tremor of the upper limbs and head (titubation — a rhythmic nodding or swaying of the head) is the presenting and early dominant feature, appearing years before any cerebellar ataxia develops.
Why it is mistaken for essential tremor
Many patients with SCA12 have carried a diagnosis of essential tremor for a decade or more. Propranolol and primidone — the standard treatments for essential tremor — do reduce the tremor of SCA12, which further reinforces the misdiagnosis. The clues that should prompt reconsideration: a family history consistent with autosomal dominant inheritance, the gradual appearance of gait unsteadiness alongside the tremor, or a positive family history of ataxia in an Agarwal patient.
A different genetic mechanism
Unlike SCA1, SCA2, SCA3, and SCA6 — where the CAG expansion sits in the coding sequence and produces an abnormally long polyglutamine tract — the SCA12 expansion is in the 5′ untranslated region of PPP2R2B. It does not produce a polyglutamine protein. Instead, the expanded repeat is thought to alter regulation of PPP2R2B expression, increasing production of the PP2A regulatory Bβ subunit in neurons and disrupting the phosphorylation balance in cerebellar Purkinje cells.
Appointment
040-44885000
A Decade of “Essential Tremor” — and One Blood Test
Most spinocerebellar ataxias present with progressive cerebellar ataxia as the dominant early feature — unsteady gait, limb incoordination, speech slurring, and nystagmus. SCA12 breaks this pattern. In the majority of patients, tremor of the upper limbs and head (titubation — a rhythmic nodding or swaying of the head) is the presenting and early dominant feature, appearing years before any cerebellar ataxia develops.
This clinical distinction matters at several levels. Essential tremor and SCA12 have different treatments, different prognoses, and completely different family implications. Essential tremor is not significantly progressive and does not cause cognitive or cerebellar deterioration; SCA12 does. A person with essential tremor does not need to inform their children of a 50% genetic risk; a person with SCA12 does.
Propranolol and primidone — the standard treatments for essential tremor — can reduce the tremor of SCA12, which further reinforces the misdiagnosis. The key clues that should prompt reconsideration: a family history consistent with autosomal dominant inheritance (parent and child affected, either sex), the gradual appearance of gait unsteadiness or balance problems alongside the tremor, or the identification of a positive family history of ataxia in an Agarwal patient.
Any patient presenting to KIMS Neuroscience with progressive tremor and a family history suggesting autosomal dominant disease, who identifies as Agarwal community, should have PPP2R2B CAG repeat sizing as a first-line investigation — before or alongside the standard essential tremor workup. This is a simple, affordable blood test that can provide a definitive diagnosis or exclusion.
Book a Consultation
Speak directly with our neurogenetics and movement disorder team — three-generation family history, PPP2R2B CAG repeat sizing, MRI where indicated, tremor management including VIM deep brain stimulation, ataxia physiotherapy, and genetic counselling with predictive testing for at-risk relatives. No referral required. Monday to Saturday.
040-44885000Emergency line: 040-46324365Symptoms of SCA12
Tremor — the defining early feature
Upper limb action tremor — present during voluntary movement rather than at rest — is the most common initial symptom, typically appearing in the fourth or fifth decade. The tremor affects the arms bilaterally but may be asymmetric early on. Head tremor (titubation) is particularly characteristic and is more common in SCA12 than in typical essential tremor. Voice tremor may also be present.
Cerebellar ataxia — appears later
Progressive gait ataxia (broad-based, unsteady gait with a tendency to fall) and limb ataxia (incoordination on finger-nose and heel-shin testing) develop over years following tremor onset. Dysarthria (slurred, scanning speech) and nystagmus develop in later stages. Balance impairment and falls become increasingly significant management issues as the disease progresses.
Cognitive and psychiatric features
Cognitive decline — predominantly affecting memory and executive function — is reported in a proportion of SCA12 patients in later stages. Psychiatric features including depression and anxiety are not uncommon. These features are more variable in SCA12 than in some other SCAs but should be assessed and managed at each review.
Pyramidal signs
Brisk deep tendon reflexes (hyperreflexia) reflecting pyramidal tract involvement are present in some patients alongside the cerebellar features. This combination is common across several SCA subtypes and does not distinguish SCA12 — but it reinforces that the condition affects multiple cerebellar-brainstem-spinal pathways, not the cerebellum alone.
Rate of progression
SCA12 generally progresses more slowly than SCA1, SCA2, or SCA3. The tremor may remain the dominant and most disabling symptom for many years before ataxia significantly impairs function. Patients often retain the ability to walk and perform most activities of daily living for a decade or more after diagnosis.
The Agarwal community association
The Agarwal community is a Hindu mercantile community originating primarily from Rajasthan and Haryana, with large populations in Delhi, Hyderabad, Mumbai, Kolkata, and across the Indian diaspora. Within this community SCA12 occurs at a frequency substantially higher than in the general Indian population — most likely a founder effect: a single ancestral PPP2R2B expansion transmitted within the community through autosomal dominant inheritance.
Diagnosis at KIMS
Diagnosis at KIMS — One Test Settles It
Clinical assessment and three-generation family history
The examination specifically assesses the character and distribution of tremor (action vs rest, arms vs head, presence of voice tremor); gait and balance (tandem walking, Romberg); coordination (finger-nose, rapid alternating movements, heel-shin); eye movements (nystagmus, saccadic pursuit, slow saccades); reflexes; and cognitive screening (MoCA). A detailed family history is essential — documenting the inheritance pattern across at least three generations where possible, with particular attention to tremor and ataxia in parents, siblings, and children.
PPP2R2B CAG repeat sizing — the definitive test
A molecular genetic blood test that counts the number of CAG repeats in the 5′ UTR of the PPP2R2B gene. A result of 66 or more CAG repeats on either allele confirms SCA12. Intermediate alleles (29–65 repeats) are of uncertain clinical significance and require specialist interpretation. At KIMS this test is coordinated through established molecular genetics laboratories; the result is typically available within 2–4 weeks. No special preparation is required — it is a standard blood draw.
MRI brain — supportive, not diagnostic
MRI in SCA12 typically shows cerebellar atrophy — particularly of the cerebellar cortex and vermis — more prominent with longer disease duration. Cerebral cortical atrophy may also be seen in later stages. These changes are not specific to SCA12 and cannot distinguish it from other cerebellar ataxias. MRI is performed primarily to exclude structural causes of ataxia and to document disease extent.
Serum investigations to exclude secondary causes
Vitamin E and B12 levels, thyroid function, and ceruloplasmin (for Wilson's disease exclusion in patients under 40) form part of the initial workup, before or alongside genetic testing.
What not to test
SCA12 does not require EMG/nerve conduction studies (there is no peripheral neuropathy in the SCA12 phenotype), lumbar puncture (CSF is normal), or cardiac assessment (SCA12 does not cause cardiomyopathy, unlike Friedreich's Ataxia). Avoiding unnecessary investigation shortens the path to the one test that settles the diagnosis.
Treatment
Tremor Management
SCA12 does not currently have an approved treatment that stops or reverses neurodegeneration. Research into PP2A pathway modulation and RNA-targeting approaches for the PPP2R2B repeat expansion is ongoing but not yet clinical. Management at KIMS is symptomatic, monitoring-based, and supportive — with genetic counselling for the whole family.
Propranolol — First-Line for Action Tremor
Beta-blocker that reduces action tremor amplitude. Effective in approximately 50–70% of SCA12 patients for the tremor component. Doses typically 40–320mg/day in divided doses.
Contraindicated in asthma, significant bradycardia, and heart block. Blood pressure and heart rate are monitored through titration.
Primidone — Alternative or Add-On
An anticonvulsant used for tremor, effective as an alternative or add-on to propranolol. Start at 25–50mg at night and titrate slowly to 250–500mg/day to avoid sedation and ataxia side effects.
Particularly useful when propranolol is contraindicated.
Clonazepam — For Head Tremor
Useful for head tremor (titubation) and when the tremor has a dystonic component. Low doses (0.25–0.5mg twice daily).
Watch for sedation and dependence with long-term use.
Botulinum Toxin and Deep Brain Stimulation
Botulinum toxin is considered for severe, treatment-refractory head tremor or focal limb tremor when oral medications are ineffective or poorly tolerated, injected into the specific muscle groups causing the tremor.
DBS targeting the ventral intermediate (VIM) nucleus of the thalamus can significantly reduce medication-refractory tremor. Evidence in SCA12 is limited to case series, but tremor-dominant SCA12 is a more favourable target for VIM DBS than ataxia-dominant SCAs. Available at KIMS.
Ataxia, Balance, and Family Care
Balance and Gait Rehabilitation
Ataxia-specific physiotherapy protocols — Frenkel exercises, task-specific balance training — slow the functional decline from cerebellar ataxia and reduce falls risk.
Walking aids (stick, rollator, or frame) are matched to gait severity, alongside falls prevention and environmental modification at home.
Adaptive Equipment for Tremor and Coordination
Weighted cutlery, stabilising devices, and writing aids for arm tremor.
Assessment and adaptation for the daily activities affected by gait and coordination impairment.
Genetic Counselling for the Whole Family
SCA12 is autosomal dominant: each child of an affected parent carries a 50% risk of inheriting the expansion, and both sexes are affected equally.
Genetic counselling is offered at diagnosis, with predictive testing available to at-risk adult family members within a structured counselling pathway.
Mood and Cognition
Depression and anxiety are assessed at each review and treated — SSRIs such as sertraline or escitalopram where indicated.
Cognitive screening (MoCA) is repeated periodically, with neuropsychological assessment where executive or memory change is suspected.
Related Conditions
SCA12 belongs to the family of genetic and developmental neurological conditions evaluated and managed at KIMS Neuroscience:
FAQs
Frequently Asked Questions
Years of tremor labelled essential tremor. A parent or a child with the same shaking. Agarwal heritage. SCA12 is the most common spinocerebellar ataxia in India, and a single blood test tells you whether that is what this is.
At KIMS Neuroscience, Secunderabad, Hyderabad, SCA12 is diagnosed by PPP2R2B CAG repeat sizing alongside a three-generation family history and clinical examination — then managed with propranolol, primidone or clonazepam for tremor, botulinum toxin or VIM deep brain stimulation for refractory tremor, ataxia-specific physiotherapy and occupational therapy, and genetic counselling with predictive testing for at-risk relatives. Call 040-44885000. No referral required.
International enquiries: info@kimsneurosciences.com